Juvaris tests flu vaccine addition

NEW YORK Burlingame, Calif.-based Juvaris BioTherapeutics is testing an adjuvant for flu vaccines.

JVRS-100, as the drug is known, is designed to augment vaccines by stimulating the immune system. Testing will involve 128 patients who will receive the drug ad an flu vaccine.

The trial will test the safety and tolerability of the drug.